General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ghannoum G et al. - The study indicates that recent clinical isolates remain susceptible to this antifungal and that MICON could be used as first-line treatment for oropharyngeal candidiasis.

Related Articles

PCR melting profile - a new tool for differentiation of Candida albicans strains
BMC Infectious Diseases, 11/13/09    Relevance Score: 66%

Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata
Mycoses, 11/05/09    Relevance Score: 66%

Distribution and hydrolytic enzyme characteristics of Candida albicans strains isolated from diabetic patients and their non-diabetic consorts
Oral Microbiology and Immunology, 10/15/09    Relevance Score: 66%

Characterization of Candida parapsilosis infection of an in vitro reconstituted human oral epithelium
European Journal of Oral Sciences, 11/16/09    Relevance Score: 65%

Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species
Journal of Medical Microbiology, 10/21/09    Relevance Score: 65%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address